By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Viamet Pharmaceuticals 

406 Blackwell Street
Suite 200
Durham  North Carolina  27701-3984  U.S.A.
Phone: 919-969-7505 Fax: n/a



Start Up

Company News
Viamet Receives Orphan Drug Designation From The FDA For VT-1598 For The Treatment Of Coccidioidomycosis 5/25/2016 10:36:33 AM
Viamet Postpones $86 Million IPO 5/12/2016 7:19:23 AM
Backed by Novartis AG (NVS), Viamet Sets Terms for $86 Million IPO 5/4/2016 6:38:31 AM
Viamet Reports Positive Results From Interim Analysis Of REVIVE Phase IIb Trial Of VT-1161 In Recurrent Vulvovaginal Candidiasis 3/9/2016 8:21:54 AM
Viamet Reports Positive Results From Interim Analysis Of RENOVATE Phase IIb Trial Of VT-1161 In Onychomycosis 3/2/2016 10:18:28 AM
Viamet To Present At The 3rd Annual Dermatology Summit 1/7/2016 11:59:57 AM
Viamet Appoints Dr. Volker Herrmann As Chief Commercial Officer 11/12/2015 11:46:45 AM
Viamet Appoints Dr. Oren Cohen As Chief Medical Officer 10/14/2015 1:05:43 PM
Viamet To Present At ICAAC/ICC 2015 9/10/2015 11:22:15 AM
Viamet And Mycoses Study Group Education & Research Consortium Establish Collaboration To Advance A Novel Therapy For Cryptococcal Meningitis 8/26/2015 10:12:39 AM